Author:
Barbier Liese,Vulto Arnold G.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. IQVIA. The Impact of Biosimilar Competition in Europe. 2020. Available from https://www.iqvia.com/library/white-papers/the-impact-of-biosimilar-competition-in-europe. Accessed 12 Oct 2021.
2. Moors EHM. Challenges for the adoption of future biosimilars. Eur J Hosp Pharm Pract. 2007;2007(13):57–8.
3. European Medicines Agency and the European Commission. Biosimilars in the EU—Information guide for healthcare professionals. 2017.
4. Dutta B, Huys I, Vulto AG, Simoens S. Identifying key benefits in European off–patent biologics and biosimilar markets : it is not only about price! BioDrugs. 2020;34(2):159–70.
5. Barbier L, Mbuaki A, Simoens S, Vulto A, Huys I. PNS151 the role of regulatory guidance and information dissemination for biosimilar medicines—the perspective of healthcare professionals and industry. Value Health. 2019;1(22):S786–7.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献